N-Acetyl L-Cysteine (NAC) Vials
|Molar Mass||163.195 g·mol−1|
|IUPAC Name||(2R)-2-acetamido-3-sulfanylpropanoic acid|
N-Acetyl L-Cysteine (NAC) is offering a high-quality and pure form of this essential substance. Within the scientific world, NAC—a derivative of the amino acid L-cysteine—is highly regarded for its many uses and beneficial characteristics.
Our N-Acetyl L-Cysteine (NAC) Vials boast key characteristics, including exceptional purity and quality. The formulation ensures that researchers have access to a reliable and uncontaminated source of NAC for their experimental endeavors.
Primarily developed for laboratory use, N-Acetyl L-Cysteine (NAC) Vials find applications in a range of research settings. Researchers can explore the diverse properties and potential applications of NAC, gaining insights into its impact on various physiological processes.
Research indicates that NAC may have potential benefits in addressing depression. Investigations suggest that the compound’s influence on glutamate levels and antioxidant properties could contribute to alleviating symptoms associated with depressive disorders.
Studies propose that NAC may be relevant in the context of autism spectrum disorders. Research findings suggest a potential role for NAC in modulating oxidative stress and neuroinflammation, offering avenues for further exploration in autism research.
NAC’s impact on cognitive function is a subject of research interest. Preliminary studies suggest that NAC may have neuroprotective effects, potentially enhancing cognitive function and protecting against cognitive decline.
In summary, N-Acetyl L-Cysteine (NAC) Vials serve as a valuable asset for researchers investigating the potential applications of this essential compound. With promising benefits related to depression, autism, and cognition, these vials offer a controlled and pure form of NAC for in-depth scientific exploration. It is crucial to emphasize that these vials are intended exclusively for research purposes, and any extrapolation to clinical use requires further investigation and validation. Researchers are encouraged to adhere to ethical guidelines and safety protocols when utilizing N-Acetyl L-Cysteine (NAC) Vials in their studies.
- Das P, Tanious M, Fritz K, Dodd S, Dean OM, Berk M, Malhi GS. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo. Aust N Z J Psychiatry. 2013 Apr;47(4):347-54. doi: 10.1177/0004867412474074. Epub 2013 Jan 22. PMID: 23341476. [Read More]
- Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, Frazier TW, Tirouvanziam R. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry. 2012 Jun 1;71(11):956-61. doi: 10.1016/j.biopsych.2012.01.014. Epub 2012 Feb 18. PMID: 22342106; PMCID: PMC4914359. [Read More]
- Remington R, Lortie JJ, Hoffmann H, Page R, Morrell C, Shea TB. A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension. J Alzheimers Dis. 2015;48(3):591-5. doi: 10.3233/JAD-150057. PMID: 26402075. [Read More]